DRW Securities, LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 97 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2018. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
DRW Securities, LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2019$105,000
-50.5%
20,100
-49.8%
0.00%
-76.9%
Q2 2018$212,000
+46.2%
40,000
+60.0%
0.01%
+44.4%
Q1 2018$145,000
+38.1%
25,000
-16.7%
0.01%
-18.2%
Q4 2017$105,00030,0000.01%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2018
NameSharesValueWeighting ↓
Versant Venture Management, LLC 5,068,233$17,739,0005.88%
Sonic Fund II, L.P. 6,552,068$22,932,0001.69%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$1,680,0000.88%
Avoro Capital Advisors LLC 6,950,000$24,325,0000.42%
RTW INVESTMENTS, LP 7,357,917$25,753,0000.39%
K2 PRINCIPAL FUND, L.P. 898,307$3,144,0000.26%
Artal Group S.A. 3,000,000$10,500,0000.21%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,827,000$9,895,0000.18%
WS MANAGEMENT LLLP 307,442$1,076,0000.11%
ALGERT GLOBAL LLC 82,145$288,0000.10%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders